Trial
NCT02764229
Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Lycera Corp.
Collaborators
—
Condition
Colitis, Ulcerative
Intervention
LYC-30937-EC
Why stopped
Lack of efficacy of test drug
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-27